Canterbury DHB

Context

June 2017

don't forget to update the issue and next review variables!!!

Changes in this release

Topic or section

Brief description

Reviewer

Myelodysplasia

We've fully reviewed this section.

Emma-Jane McDonald

Drug Usage in Haematology

  • We've added the Rituximab and Oral Fludarabine chart to Prescription Charts under Waldenstroms.
  • We've updated the Mantle Cell Maxi HDcytarabine, Mantle Cell Maxi CHOP, Mini R CHOP, and CHOEP charts under Non Hodgkin Lymphoma.
  • We've added Rituximab + Bendamustine to the Non Hodgkin Lymphoma Prescription Charts.
  • We've added Rituximab + Bendamustine Cycle 1 and Rituximab + Bendamustine Cycles 2 + to the Chronic Lymphocytic Leukaemia Prescription Charts.

Fiona Stone

Supportive Care

We've updated the Safe Eating and Low Immunity Diet Guidelines in Levels of Nutrition Support.

Lizzie Hammond

Drug Usage in Haematology

Fiona Stone / Lizzie Hammond

Plasma Cell Neoplasms

We've updated text in Investigations Required for the New Patient Likely to Receive Intensive Treatment

Lizzie Hammond

Stem Cell Transplantation

We've added information about rituximab in Viral infection in SCT under heading EBV.

Andrew Butler

About this Canterbury DHB document (397572):

Document Owner:

Not assigned (see Who's Who)

Issue Date:

Next Review:

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 397572